22 results on '"Brown, K.K."'
Search Results
2. The MUC5B Genotype and Other Common Variants Are Associated With Computational Imaging Features of Usual Interstitial Pneumonia Pattern Among Patients With Idiopathic Pulmonary Fibrosis
3. Fibrosis Scores Per Quantitative High-resolution Computed Tomography at Baseline and the Change Over One Year Predict Subsequent Progressive Pulmonary Fibrosis at 24 Months
4. How Should Patients With Progressive Pulmonary Fibrosis Be Identified? Consensus Findings From a Modified Delphi Study
5. Quantitative High-Resolution Computed Tomography Predicts Progressive Pulmonary Fibrosis
6. Somatic Mutations of MUC5B Within Lung Tissue in Idiopathic Pulmonary Fibrosis
7. Neutrophil Extracellular Trap Associated Proteins in Bronchoalveolar Lavage Fluid Are Associated With Worse Baseline Lung Function and Worse Survival in Patients With Idiopathic Pulmonary Fibrosis
8. Incremental Healthcare Utilization and Cost Burden Associated with Non-IPF Chronic Fibrosing Interstitial Lung Disease (ILD) with a Progressive Phenotype
9. A Multi-Omic Approach to Understanding the Molecular Landscape of IPF
10. An Adjudication Algorithm for Respiratory-Related Hospitalization in Idiopathic Pulmonary Fibrosis
11. Chronic Hypersensitivity Pneumonitis (CHP), an Interstitial Lung Disease (ILD) with Distinct Molecular Signatures
12. Cardiopulmonary Exercise Test Profile in Hypersensitivity Pneumonitis
13. RANKL Dependent Differentiation of Pulmonary Osteoclast-Like Cells in Silica-Induced Pulmonary Fibrosis
14. Study Design of a Phase III, Randomized, Placebo-Controlled Trial of Nintedanib in Children and Adolescents with Clinically Significant Fibrosing Interstitial Lung Disease (ILD)
15. Among Individuals At-Risk, Pre-Clinical Pulmonary Fibrosis Occurs Commonly and Is Progressive
16. Circulating Plasma Proteins Differentially Detected in Idiopathic Pulmonary Fibrosis and in Subjects with Pre-Clinical Pulmonary Fibrosis
17. Rationale, Design and Objectives of Two Phase III, Randomised, Placebo-Controlled Studies of GLPG1690, a Novel Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (ISABELA 1 and 2)
18. Recurrent Acute Exacerbations of Fibrotic Interstitial Lung Diseases
19. Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis
20. An Update on the Global Idiopathic Pulmonary Fibrosis (IPF) Collaborative Network: A Platform for IPF Genetics
21. The Global Idiopathic Pulmonary Fibrosis (IPF) Collaborative Network: A Platform for IPF Genetics
22. Decline in pulmonary physiology during treatment of chronic hepatitis C with long-acting interferons and ribavirin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.